LD50=4 gm/kg (orally in mice); LD50=3650 mg/kg (orally in rabbits)
An antitubercular agent often administered in association with isoniazid. The sodium salt of the drug is better tolerated than the free acid.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ammonium chloride | The serum concentration of Aminosalicylic acid can be increased when it is combined with Ammonium chloride. |
| Ginkgo biloba | The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Aminosalicylic acid. |
| Methotrexate | The serum concentration of Methotrexate can be increased when it is combined with Aminosalicylic acid. |
| Pralatrexate | The serum concentration of Pralatrexate can be increased when it is combined with Aminosalicylic acid. |
| Probenecid | The therapeutic efficacy of Probenecid can be decreased when used in combination with Aminosalicylic acid. |
| Treprostinil | The risk or severity of bleeding can be increased when Treprostinil is combined with Aminosalicylic acid. |
| Prilocaine | The risk or severity of methemoglobinemia can be increased when Aminosalicylic acid is combined with Prilocaine. |
| Picosulfuric acid | The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Aminosalicylic acid. |
| Ketoprofen | The risk or severity of bleeding and gastrointestinal bleeding can be increased when Aminosalicylic acid is combined with Ketoprofen. |
| Dexketoprofen | The risk or severity of bleeding and gastrointestinal bleeding can be increased when Aminosalicylic acid is combined with Dexketoprofen. |
| Dicoumarol | Aminosalicylic acid may increase the anticoagulant activities of Dicoumarol. |
| Phenindione | Aminosalicylic acid may increase the anticoagulant activities of Phenindione. |
| Warfarin | Aminosalicylic acid may increase the anticoagulant activities of Warfarin. |
| Phenprocoumon | Aminosalicylic acid may increase the anticoagulant activities of Phenprocoumon. |
| Acenocoumarol | Aminosalicylic acid may increase the anticoagulant activities of Acenocoumarol. |
| 4-hydroxycoumarin | Aminosalicylic acid may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Coumarin | Aminosalicylic acid may increase the anticoagulant activities of Coumarin. |
| (R)-warfarin | Aminosalicylic acid may increase the anticoagulant activities of (R)-warfarin. |
| Ethyl biscoumacetate | Aminosalicylic acid may increase the anticoagulant activities of Ethyl biscoumacetate. |
| Fluindione | Aminosalicylic acid may increase the anticoagulant activities of Fluindione. |
| Clorindione | Aminosalicylic acid may increase the anticoagulant activities of Clorindione. |
| Diphenadione | Aminosalicylic acid may increase the anticoagulant activities of Diphenadione. |
| Tioclomarol | Aminosalicylic acid may increase the anticoagulant activities of Tioclomarol. |
| (S)-Warfarin | Aminosalicylic acid may increase the anticoagulant activities of (S)-Warfarin. |
| Digoxin | The serum concentration of Digoxin can be decreased when it is combined with Aminosalicylic acid. |
| Acetyldigitoxin | The serum concentration of Acetyldigitoxin can be decreased when it is combined with Aminosalicylic acid. |
| Deslanoside | The serum concentration of Deslanoside can be decreased when it is combined with Aminosalicylic acid. |
| Ouabain | The serum concentration of Ouabain can be decreased when it is combined with Aminosalicylic acid. |
| Digitoxin | The serum concentration of Digitoxin can be decreased when it is combined with Aminosalicylic acid. |
| Oleandrin | The serum concentration of Oleandrin can be decreased when it is combined with Aminosalicylic acid. |
| Cymarin | The serum concentration of Cymarin can be decreased when it is combined with Aminosalicylic acid. |
| Proscillaridin | The serum concentration of Proscillaridin can be decreased when it is combined with Aminosalicylic acid. |
| Metildigoxin | The serum concentration of Metildigoxin can be decreased when it is combined with Aminosalicylic acid. |
| Lanatoside C | The serum concentration of Lanatoside C can be decreased when it is combined with Aminosalicylic acid. |
| Gitoformate | The serum concentration of Gitoformate can be decreased when it is combined with Aminosalicylic acid. |
| Acetyldigoxin | The serum concentration of Acetyldigoxin can be decreased when it is combined with Aminosalicylic acid. |
| Peruvoside | The serum concentration of Peruvoside can be decreased when it is combined with Aminosalicylic acid. |
| Dapsone | The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Aminosalicylic acid. |
| Tioguanine | The metabolism of Tioguanine can be decreased when combined with Aminosalicylic acid. |
| Azathioprine | The metabolism of Azathioprine can be decreased when combined with Aminosalicylic acid. |
| Mercaptopurine | The metabolism of Mercaptopurine can be decreased when combined with Aminosalicylic acid. |
| Lepirudin | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Lepirudin. |
| Bivalirudin | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Bivalirudin. |
| Alteplase | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Alteplase. |
| Urokinase | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Urokinase. |
| Reteplase | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Reteplase. |
| Anistreplase | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Anistreplase. |
| Tenecteplase | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Tenecteplase. |
| Abciximab | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Abciximab. |
| Drotrecogin alfa | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Drotrecogin alfa. |
| Streptokinase | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Streptokinase. |
| Argatroban | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Argatroban. |
| Ardeparin | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Ardeparin. |
| Fondaparinux | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Fondaparinux. |
| Pentosan polysulfate | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Pentosan polysulfate. |
| Dipyridamole | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Dipyridamole. |
| Heparin | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Heparin. |
| Enoxaparin | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Enoxaparin. |
| Epoprostenol | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Epoprostenol. |
| Ximelagatran | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Ximelagatran. |
| Desmoteplase | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Desmoteplase. |
| Defibrotide | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Defibrotide. |
| Ancrod | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Ancrod. |
| Beraprost | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Beraprost. |
| Prasugrel | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Prasugrel. |
| Rivaroxaban | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Rivaroxaban. |
| Sulodexide | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Sulodexide. |
| Semuloparin | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Semuloparin. |
| Idraparinux | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Idraparinux. |
| Cangrelor | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Cangrelor. |
| Astaxanthin | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Astaxanthin. |
| Apixaban | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Apixaban. |
| Otamixaban | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Otamixaban. |
| Amediplase | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Amediplase. |
| Dabigatran etexilate | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Dabigatran etexilate. |
| Danaparoid | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Danaparoid. |
| Dalteparin | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Dalteparin. |
| Tinzaparin | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Tinzaparin. |
| Nadroparin | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Nadroparin. |
| Triflusal | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Triflusal. |
| Ticagrelor | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Ticagrelor. |
| Ditazole | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Ditazole. |
| Vorapaxar | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Vorapaxar. |
| Edoxaban | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Edoxaban. |
| Sodium citrate | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Sodium citrate. |
| Dextran | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Dextran. |
| Bemiparin | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Bemiparin. |
| Parnaparin | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Parnaparin. |
| Desirudin | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Desirudin. |
| Antithrombin Alfa | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Antithrombin Alfa. |
| Protein C | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Protein C. |
| Antithrombin III human | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Antithrombin III human. |
| Letaxaban | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Letaxaban. |
| Darexaban | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Darexaban. |
| Betrixaban | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Betrixaban. |
| Nafamostat | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Nafamostat. |
| Monteplase | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Monteplase. |
| Gabexate | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Gabexate. |
| Protein S human | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Protein S human. |
| Brinase | The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Brinase. |